Prostates, Prunus and policy: A remarkable tree, a contested study, and tough choices ahead

The sustainability of tree-bark harvesting of the Prunus africana tree — the source of an important medicine used to treat benign prostate hyperplasia — is under debate, with a report extolling the potential for sustainably harvested tree bark now being contested. This case holds lessons about policy development, forest governance and trade.This article was originally posted on Forests News. Click here to read the full article.